Pfizer announced that its drug, Adcetris, extended survival in patients with the most common type of lymphoma in a late-stage study, bolstering efforts to expand the use of the treatment gained through its $43 billion purchase of Seagen. The New York-based drugmaker last year struck a deal to acquire Seagen and its targeted cancer therapies
Senior Biden administration officials recently pressed the CEO of healthcare giant UnitedHealth Group and other healthcare firms to do more to get vital payments flowing to healthcare providers three weeks after a cyberattack crippled those payment systems, according to sources. The meeting featured Health and Human Services Secretary Xavier Becerra, senior White House officials, and
The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions.
